The impact of FLIPI on outcome of frontline treatment with single-agent I-131 tositumomab for follicular lymphoma (FL)

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 4 de junio del 2006

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016